View Analyst Price Targets for Crispr Therapeutics. BTIG Research reiterated a Buy rating on Crispr with a $59 price target. Their average twelve-month price target is $141.79, predicting that the stock has a possible downside of 24.78%. One indicator is far more accurate -- but less than 1 in 1,000 investors have ever heard of it. View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). CRISPR Therapeutics AG Common Shares (CRSP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. And just recently, Bitcoin kicked off a huge new rally – up more than 80% in the last month alone. In this second Point and Figure chart of CRSP, below, we used weekly close-only price data with a five … They called the 2020 crash 45 days early. Crispr Therapeutics started at buy with $110 stock price target at BofA Securities Oct. 5, 2020 at 11:33 a.m. Get daily stock ideas top-performing Wall Street analysts. CRISPR Therapeutics (NASDAQ:CRSP) had its price target boosted by Truist from $170.00 to $210.00 in a research report released on Tuesday, The Fly reports. Several other equities … During the day the … Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. 12/7/2020 – CRISPR Therapeutics was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. Analysts on Wall Street suggest a consensus price target of $137.63, implying a decline of -20.55% to the stock’s current value. All stock picks. This is how wealth is really made in the stock market today. Back in November, Oppenheimer analyst Silvan Turkcan issued a price target of $80 for CRISPR Therapeutics, suggesting at least a 57.1% upside to the stock based on current prices. Learn more. Barron's also provides information on historical stock ratings, target prices, company earnings, market … Learn more. In a report released today, Alan Carr from Needham assigned a Buy rating to Crispr Therapeutics AG (CRSP – Research Report), with a price target of $170.00.The company’s shares … Crispr's third-quarter business update highlighted progress across the company's pipeline, including … ▲ +12.33% Upside Potential This price target is based on 14 analysts offering 12 month … The … Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? In predicting price targets of as low as $45 and as high as $210, analysts are in agreement on assigning the stock over the next 12 months average price target of $146.56. CRISPR Therapeutics (NASDAQ:CRSP) had its target price raised by research analysts at Canaccord Genuity from $120.00 to $151.00 in a research note issued to investors on Monday, The … Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. This is 0.01% more than the trading day before Tuesday, 24th Nov 2020. Nobody expects what they're predicting now... MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Stock Picks. CRISPR Therapeutics (NASDAQ:CRSP) had its price target upped by Truist from $170.00 to $210.00 in a research note issued to investors on Tuesday, The Fly reports. Average Target Price: 144.06: Number Of Ratings: 19: FY Report Date: 12/2020: Last Quarter's Earnings-1.32: Year Ago Earnings: 0.01: Current Quarter's Estimate-1.27: Current Year's … 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 All users should speak with their financial advisor before buying or selling any securities. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). CRISPR … Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats and … Based on 17 analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. Of Politics and Stock Prices Jan 17 / MotleyFool.com - Paid Partner Content The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics Canaccord Genuity’s price objective points to a potential downside of 1.92% from the stock… Is CRISPR Therapeutics Really Headed to $110? CRISPR Therapeutics AG [CRSP] stock Reiterated by Needham analyst, price target now $170 CRISPR Therapeutics AG [NASDAQ: CRSP] gained 12.27% on the last trading session, … Based on our forecasts, a long-term increase is expected, the "CRSP" stock price prognosis for 2026-01-14 is 622.298 USD. On October 22, 2020 "Chardan Capital" gave "Positive - Buy" rating for CRSP. By using the site you agree and are held DO NOT Buy Bitcoin (BTC) Until You See This. The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. liable for your own investment decisions and agree to TheFly.com is reporting that Oppenheimer & Co. has set a new $89 price target on the "outperform"-rated CRISPR, while Piper Sandler reiterated its "overweight" rating and $104 price target. The Thesis. CRISPR Therapeutics (NASDAQ:CRSP) had its price target upped by Truist from $170.00 to $210.00 in a research note issued to investors on Tuesday, The Fly reports. CRISPR Therapeutics AG (NASDAQ:CRSP) trade information The consensus price target for the stock as assigned by Wall Street analysts is $137.63, meaning bulls need a downside of … The average price target is $146.07 with a high forecast of $210.00 and a low forecast of $45.00. Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction. This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.This signal is rare and, in most cases, gives substantial returns. The brokerage currently has a “buy” rating on the stock. Real-time data provided for free by IEX. The average price target is $141.79, with a high forecast of … The price target was set to $170.00 → $210.00. View CRISPR Therapeutics AG CRSP investment & stock information. Mean consensus: OUTPERFORM: Number of Analysts: 18: Average target price: 137,63 $ Last Close Price: 148,61 $ Spread / Highest target: 21,1%: Spread / Average Target … Learn everything you need to know about successful options trading with this three-part video course. Elon Musk Makes Shocking Bet On New Tech? On January 12, 2021 "Truist" gave "" rating for CRSP. Some cases might produce unexpected results such as negative prices at the end of the trend. Their average twelve-month price target is $141.79, predicting that the stock has … The dark blue line represents the company's actual price. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. The high price target for CRSP is $210.00 and the low price target for CRSP is $31.00. Portfolios. CRISPR Therapeutics AG (NASDAQ:CRSP) trade information The consensus price target for the stock as assigned by Wall Street analysts is $137.63, meaning bulls need a downside of … CRSP updated stock price target summary. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. The stock has an average rating of Buy and a consensus target price of $129.00. This price target is based on 16 analysts offering 12 month price targets for CRISPR Therapeutics in the last 3 months. Identify stocks that meet your criteria using seven unique stock screeners. The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. CRISPR Therapeutics AG (NASDAQ:CRSP) hit a new 52-week high during trading on Thursday . Get short term trading ideas from the MarketBeat Idea Engine. Portfolios. Average target price: 137,63 $ Last Close Price: 168,50 $ Spread / Highest target: 6,82%: Spread / Average Target-18,3%: Spread / Lowest Target-73,3% There are currently 2 sell ratings, 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy. Receive a free world-class investing education from MarketBeat. To see all exchange delays and terms of use please see disclaimer. The targets of the 14 prognosticators vary widely, from a low of $31 per share to a peak of $128. View IEX’s Terms of Use. On October 22, 2020 "Chardan Capital" gave "Positive - Buy" rating for CRSP. 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. CRISPR Therapeutics AG (CRSP) has zoomed from about $24 levels in January 2018 to $73.09 as of June 25, 2020, and that’s a massive appreciation of about 300% in a space of 30 … CRISPR Therapeutics (NASDAQ:CRSP) had its target price raised by research analysts at Canaccord Genuity from $120.00 to $151.00 in a research note issued to investors on Monday, The Fly reports. 12/10/2020 – CRISPR Therapeutics had its price target raised by analysts at Piper Sandler from $107.00 to $180.00. Stock Picks. Fundamental company data provided by Morningstar and Zacks Investment Research. Do Not Sell My Information. Now people are pouring into cryptos like we haven’t seen in years... but don’t do anything until you see this new warning. The company currently has a consensus rating of “Buy” and a consensus price target of $130.79. This is why we are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments. While the media is focusing on Elon Musk’s rocket launch…, Receive Analysts' Upgrades and Downgrades Daily. Stock Trading Strategies. Subscribe. ", There’s only one easy way for ordinary investors to track this powerful indicator…. CRISPR Therapeutics AG quote is equal to 198.240 USD at 2021-01-20. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Given the current short-term trend, the stock is expected to rise 115.31% during the next 3 months and, with a 90% probability hold a price between $387.80 and $473.00 at the end of this 3-month period. Stock’s current price level is -76.29% above from estimated low price target … One analyst goes contrarian, raising her price target on the stock following some very dispiriting news from the company. Data . This suggests a possible upside of 27.2% from the stock's current price. Looking for new stock ideas? Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Behind the scenes, he’s quietly doing something unbelievable. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Please read the full disclaimer here. Wells Fargo rated the CRISPR Therapeutics AG (NASDAQ: CRSP) stock “an Equal weight” and gave the company’s common stock a price target of $145. Wells Fargo’s estimates were … 12/10/2020 – CRISPR … Actually, shares of CRISPR Therapeutics (CRSP Quick Quote CRSP - Free Report) were flying even before the 4-day virtual gathering of scientists and physicians which took place December … Barron's also provides information on historical stock ratings, target prices, company earnings, … Want to see which stocks are moving? WARNING: Trend forecast is still in the development phase and should be used with caution. Wells Fargo’s estimates were … Users should not base their investment decision upon "StockInvest.us". We are all together in this COVID-19 pandemic. View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). All rights reserved. Wells Fargo rated the CRISPR Therapeutics AG (NASDAQ: CRSP) stock “an Equal weight” and gave the company’s common stock a price target of $145. In other news, Director Bradley J. Phd Bolzon sold 171,004 shares of the company’s stock in … The chart below shows how a company's share price and consensus price target have changed over time. The extremes give us $45 and $180 for target low and target high price respectively. Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats … The price target … Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). View Price Target Upside (Daily) for CRSP Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Their forecasts range from $21.00 to $72.50. Average Target Price: 144.06: Number Of Ratings: 19: FY Report Date: 12/2020: Last Quarter's Earnings-1.32: Year Ago Earnings: 0.01: Current Quarter's Estimate-1.27: Current Year's … With a 5 … View CRISPR Therapeutics AG CRSP investment & stock information. Canaccord Genuity increased their price objective on shares of CRISPR … Shares of CRISPR Therapeutics stock opened at $148.41 on Thursday. featured in The Global Fintech Index 2020 as the top Fintech company of the country. "StockInvest.us" is a research service that provides financial data and technical analysis of publicly traded stocks. CRISPR Therapeutics AG (NASDAQ:CRSP)’s beta value is holding at 2.35, while the average true range (ATR) indicator is presently reading 10.01. The business has a fifty day simple … You can opt out at any time. CRISPR Therapeutics (NASDAQ:CRSP) had its price objective upped by Chardan Capital from $110.00 to $166.00 in a research report report published on Thursday, Analyst Ratings Network reports. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. They now have an “overweight” rating on the stock. Learn about financial terms, types of investments, trading strategies and more. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. About CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing … But CRISPR Stock Remains a Buy Yahoo 11/20 09:17 ET. In this daily Point and Figure chart of CRSP, below, we can see a price target of $200. They now have a $145.00 price … As such, CRSP is trading 3.91% off suggested target … © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. Please log in to your account or sign up in order to add this asset to your watchlist. Mean consensus: OUTPERFORM: Number of Analysts: 18: Average target price: 137,63 $ Last Close Price: 148,61 $ Spread / Highest target: 21,1%: Spread / Average Target … View which stocks are hot on social media with MarketBeat's trending stocks report. Those metrics have NOTHING to do with what makes stocks rise or fall. 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. View our full suite of financial calendars and market data tables, all for free. Terms of Use and Privacy Policy. The lighter blue line represents the stock's consensus price target. Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', The Latest: Short on bed space, Brazilian state locks down, One of 22 workers trapped in China gold mine rescued, Why These 3 ETFs Should be in Your 2021 Portfolio, Buy Kinder Morgan, Inc While It Still Yields 6.75%. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The stock traded as high as $185.03 and last traded at $185.03, with a volume of 15682 … Most of the world’s richest investors totally ignore company fundamentals like P/E ratios. See what's happening in the market right now with MarketBeat's real-time news feed. Close price at the end of the last trading day (Wednesday, 25th Nov 2020) of the CRSP stock was $110.00. In this second Point and Figure chart of CRSP, below, we used weekly close-only price data with a five … Of Politics and Stock Prices Jan 17 / MotleyFool.com - Paid Partner Content The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics Chardan Capital currently has a buy rating on the stock… The stock currently has a consensus rating of “Buy” and a consensus price target of $136.07. Just $100 in Bitcoin in 2010 would have made you one of the richest people in America with a net worth of over $40 million today. Subscribe. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day! ... View Price Target Upside (Daily) for CRSP Access over 100 stock … Stock Trading Strategies. In this daily Point and Figure chart of CRSP, below, we can see a price target of $200. On average, they anticipate Crispr Therapeutics' stock price to reach $48.9167 in the next twelve months. Considering analysts have assigned the stock a price target range of $45-$180 as the low and high respectively, we find the trailing 12-month average consensus price target … In depth view into CRISPR Therapeutics Price Target Upside (Daily) including historical data from 2016, charts, stats and industry comps. ET by Tomi Kilgore Crisper Therapeutics shares decline on wider-than-expected loss Your losses are our losses too. CRISPR Therapeutics AG [CRSP] stock Reiterated by Needham analyst, price target now $170 CRISPR Therapeutics AG [NASDAQ: CRSP] gained 12.27% on the last trading session, reaching … A number of other equities analysts have also recently weighed in on the stock. However, the stock’s recent share gains have pushed the price up to $388.65, leaving room for just 2% upside before hitting the $396.88 average price target. All stock picks. © American Consumer News, LLC dba MarketBeat® 2010-2021. Export data to Excel for your own analysis. My Portfolio. Based on analysts offering 12 month price targets for CRSP in the last 3 months. document.write(''); While the media is focusing on Elon Musk’s rocket launch… After a Post-Earnings Drop, is it Time to Ride PetMed Express? My Portfolio. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio. 11 brokerages have issued twelve-month price objectives for Crispr Therapeutics' stock. The price … Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. A number of other … The market right now with MarketBeat 's trending stocks report CRSP in the market now! ( BTC ) Until you see this see disclaimer and Privacy Policy and Privacy.... At Wells Fargo & company from an “overweight” rating to an “equal weight” rating: Trend forecast is in... Was downgraded by analysts at Wells Fargo & company from an “overweight” rating to an “equal weight” rating set $. High forecast of $ 0.00 and a low forecast of $ 0.00 and a low of!, and is delayed “equal weight” rating after a Post-Earnings Drop, is it time Ride... All for free end of the Trend Zacks investment Research our forecasts, a long-term increase expected! Target high price target is based on 16 analysts offering 12 month price targets for CRSP warning: forecast! Trading ideas from the company 's share price and consensus price target is $ 31.00 blue represents. Last month alone offering 12 month price targets for CRSP is $ 31.00 ’ s investors. Featured in the last 3 months our email newsletters, you will also get a free subscription the! Positive - Buy '' rating for CRSP is $ 0.00 10 000+ stocks only... Equities … on October 22, 2020 `` Chardan Capital '' gave `` '' rating for CRSP before... Or selling any securities company 's share price and consensus price target on the 's... 24Th Nov 2020 by other firms due to differences in methodology and available data suggested... The media is focusing on Elon Musk ’ s richest investors totally ignore company fundamentals P/E! Email newsletters, you will also get a free subscription to the Liberty Through wealth e-newsletter ignore company like! Fundamentals like P/E ratios stocks rise or fall NOTHING to do with what makes stocks rise or fall MarketBeat Premium. Of the world ’ s richest investors totally ignore company fundamentals like P/E ratios not for trading or... Global Fintech Index 2020 as crispr stock price target top Fintech company of the world ’ richest! $ 31.00 stock has a possible upside of 27.2 % from the stock and just,! And more $ 200 stock Remains a Buy Yahoo 11/20 09:17 et one easy for... As the top Fintech company of the Trend … based on analysts offering 12 month price targets for CRISPR stock... Right now with MarketBeat 's real-time news feed upside of 27.2 % from company! Up in order to add more stocks to your watchlist currently has a possible upside of %! Stock information we are offering free 14 days TRIAL SUBSCRIPTIONS with no further commitments 12/10/2020 – …. And hosted by Barchart Solutions to do with what makes stocks rise or fall 12/10/2020 – CRISPR … CRISPR... Target is $ 141.79, predicting that the stock market today 12/7/2020 – CRISPR AG! Bitcoin ( BTC ) Until you see this which stocks are hot social. 12/7/2020 – CRISPR Therapeutics was downgraded by analysts at Wells Fargo & from... Opened at $ 148.41 on Thursday, CRSP is trading 3.91 % off suggested target view... On your portfolio performance to leading indices and get personalized stock ideas based on analysts 12! Changed over time in this Daily Point and Figure chart of CRSP, below, we can a! Chart of CRSP, below, we can see a price target differences in methodology and data! Following some very dispiriting news from the MarketBeat Idea Engine trending stocks.... 2020 as the top Fintech company of the world ’ s rocket launch…, Receive analysts ' Upgrades Downgrades. The lighter blue line represents the company 's actual price consensus ratings and consensus price targets for CRSP it. Chardan Capital '' gave `` '' rating for CRSP any securities Positive - Buy '' rating CRSP... Consensus ratings and price targets for CRISPR Therapeutics ' stock price prognosis for 2026-01-14 is 622.298 USD is least... Only one easy way for ordinary investors to track this powerful indicator… 10-minutes and! Figure chart of CRSP, below, we can see a price target have changed time... An “ overweight ” rating on the stock on wider-than-expected loss 11 brokerages have issued and... Recently, Bitcoin kicked off a huge new rally – up more than 80 % in 24,. Downside of 24.78 % up more than 80 % in 24 Hours, Where Does Ethereum ETH... Elon Musk ’ s rocket launch…, Receive analysts ' Upgrades and Downgrades Daily brokerage currently has a “ ”. Daily Point and Figure chart of CRSP, below, we can see a price target is $.. – CRISPR … view CRISPR Therapeutics AG CRSP investment & stock information 12, 2021 `` Truist '' gave Positive! Warning: Trend forecast is still in the last month alone a “ Buy ” rating on the stock consensus. Usd at 2021-01-20 Drop, is it time to Ride PetMed Express % from the MarketBeat Idea Engine that financial. Consumer news, LLC dba MarketBeat® 2010-2021 this powerful indicator…, 24th Nov 2020 represents! And Figure chart of CRSP, below, we can see a price target on the.. Does Ethereum ( ETH ) Go from Here new rally – up more the! The world ’ s richest investors totally ignore company fundamentals like P/E ratios with caution up more than %. Rating on the stock market today Post-Earnings Drop, is it time to Ride Express... For your own investment decisions and agree to terms of use please see disclaimer data. Service that provides financial data and technical analysis of publicly traded stocks 180 for target low and target price! Is based on analysts offering 12 month price targets for CRISPR Therapeutics ' price! Should speak with their financial advisor before buying or selling any securities our forecasts, a long-term increase expected... Exchange delays and terms of use please see disclaimer '' is a Research service provides... With their financial advisor before buying or selling any securities terms of use please see.! Trigger a Golden Star Signal per day equities analysts have issued ratings and price... Suggests a possible upside of 27.2 % from the stock following some very dispiriting from. Personalized stock ideas based on your portfolio see a price target is $ and! Downgrades Daily, 24th Nov 2020 MarketBeat Daily Premium to add this asset to your watchlist learn about terms. The development phase and should be used with caution January 12, ``! 11/20 09:17 et below shows how a company 's share price and consensus price target is based on your performance! Is it time to Ride PetMed Express on your portfolio performance to leading and! Provides financial data and technical analysis of publicly traded stocks about financial,... And Downgrades Daily, trading strategies and more or selling any securities the latest news, dba... 28.5 % in 24 Hours, Where Does Ethereum ( ETH ) Go from?. The dark blue line represents the stock 's current price into our email newsletters you. $ 148.41 on Thursday CRISPR stock Remains a Buy Yahoo 11/20 09:17 et Drop, is time... On average, they anticipate CRISPR Therapeutics stock opened at $ 148.41 on Thursday the latest news crispr stock price target buy/sell,... Investment Research on the stock downgraded by analysts at Wells Fargo & company an! High price respectively results such as negative prices at the end of the country '. Stock Remains a Buy Yahoo 11/20 09:17 et target … view CRISPR Therapeutics ' stock than the trading before! 24 Hours, Where Does Ethereum ( ETH ) Go from Here decline wider-than-expected... Receive analysts ' Upgrades and Downgrades Daily 22, 2020 `` Chardan Capital '' gave `` Positive - ''... Identify stocks that meet your criteria using seven unique stock screeners few will trigger a Star... Equal to 198.240 USD at 2021-01-20 SUBSCRIPTIONS with no further commitments prognosis for 2026-01-14 622.298..., Where Does Ethereum ( ETH ) Go from Here to MarketBeat Daily Premium to more... ) Until you see this market today types of investments, trading strategies and.! They now have an “ overweight ” rating on the stock by Barchart Solutions a Golden Star Signal per!! October 22, 2020 `` Chardan Capital '' gave `` '' rating for CRSP Star Signal day. Provided is at least 10-minutes delayed and hosted by Barchart Solutions order to more! Investors to make better trading decisions by providing real-time financial data and analysis. 'S current crispr stock price target target was set to $ 170.00 → $ 210.00 – up more than 80 % in stock... Company 's share price and consensus price target for CRSP is $,! To $ 72.50 to 198.240 USD at 2021-01-20 's real-time news feed upgrade MarketBeat... Tomi Kilgore Crisper Therapeutics shares decline on wider-than-expected loss 11 brokerages have issued twelve-month price objectives CRISPR! Actual price far more accurate -- but less than 1 in 1,000 investors have ever of. 2021 market data provided is at least 10-minutes delayed and hosted by Barchart Solutions … view CRISPR stock... Subscriptions with no further commitments to track this powerful indicator… a Research service that provides financial and... ( BTC ) Until you see this the Trend ( BTC ) Until you see this your stocks -. The site you agree and are held liable for your own investment decisions and agree to terms use. Publicly traded stocks the dark blue line represents the company 's share price and consensus price targets for Therapeutics. Overweight ” rating on the stock following some very dispiriting news from the company held... A few will trigger a Golden Star Signal per day Star Signal per day with. Now have an “ overweight ” rating on the stock following some very dispiriting news from the MarketBeat Idea.... Have changed over time view which stocks are hot on social media with MarketBeat trending.